about
Molecular cloning and expression of a cDNA encoding the secretin receptorStructure, expression, and chromosomal localization of the type I human vasoactive intestinal peptide receptor geneNeuroprotective strategy for Alzheimer disease: intranasal administration of a fatty neuropeptide.Premature primary tooth eruption in cognitive/motor-delayed ADNP-mutated childrenTherapeutic potential of vasoactive intestinal peptide and its receptors in neurological disorders.Vasoactive intestinal peptide increases intracellular calcium in astroglia: synergism with alpha-adrenergic receptors.Characterisation of the mouse vasoactive intestinal peptide receptor type 2 gene, Vipr2, and identification of a polymorphic LINE-1-like sequence that confers altered promoter activity.A fatty neuropeptide. Potential drug for noninvasive impotence treatment in a rat model.Intestinotrophic glucagon-like peptide-2 (GLP-2) activates intestinal gene expression and growth factor-dependent pathways independent of the vasoactive intestinal peptide gene in micePharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1.Class II G protein-coupled receptors and their ligands in neuronal function and protectionSuprachiasmatic nucleus of the human brain: an immunocytochemical and morphometric analysis.Phenotypic plasticity in adult sympathetic neurons: changes in neuropeptide expression in organ cultureExpression of galanin and a galanin receptor in several sensory systems and bone anlage of rat embryos.Excitatory actions of peptide histidine isoleucine on thalamic relay neurons.Microarray analyses of pituitary adenylate cyclase activating polypeptide (PACAP)-regulated gene targets in sympathetic neurons.A femtomolar-acting neuroprotective peptideTranslational control of entrainment and synchrony of the suprachiasmatic circadian clock by mTOR/4E-BP1 signaling.The physiological roles of secretin and its receptor.The importance of neuronal growth factors in the ovary.Defects in the vasoactive intestinal peptide (VIP)/VPAC system during early stages of the placental-maternal leucocyte interaction impair the maternal tolerogenic response.Breaking human cytomegalovirus major immediate-early gene silence by vasoactive intestinal peptide stimulation of the protein kinase A-CREB-TORC2 signaling cascade in human pluripotent embryonal NTera2 cells.Active immunization against vasoactive intestinal polypeptide decreases neuronal recruitment and inhibits reproduction in zebra finches.The effects of ribavirin on the GTP level and the VIP receptor dynamic of human IGR39 cells.Study of NO and VIP as non-adrenergic non-cholinergic neurotransmitters in the pig gastric fundus.Characterization of the rat vasoactive intestinal polypeptide receptor gene 5' region.Influence of age on the signal transduction pathway of non-adrenergic non-cholinergic neurotransmitters in the rat gastric fundus.Evidence of a functional VIP receptor in cultured human retinal pigment epithelium.Vasoactive intestinal peptide selectively depolarizes thalamic relay neurons and attenuates intrathalamic rhythmic activity.High conservation of upstream regulatory sequences on the human and mouse vasoactive intestinal peptide (VIP) genes.Steroid Regulation of Vasoactive Intestinal Peptide (VIP).Excitatory actions of vasoactive intestinal peptide on mouse thalamocortical neurons are mediated by VPAC2 receptors.Evidence for a direct neuronal pathway from the suprachiasmatic nucleus to the gonadotropin-releasing hormone system: combined tracing and light and electron microscopic immunocytochemical studies.VPAC1 overexpression is associated with poor differentiation in colon cancer.
P2860
Q24561434-5EBB6F9A-497D-4944-91F1-9900E36B1D81Q24564119-B2994D83-144C-43A3-9CEB-12F316D064B4Q33628181-45ECBCDD-6384-4AE8-AE7F-D90A6890D99CQ33707712-9A17ED39-9AAC-4839-9EAB-07F512B3F15FQ34259060-C96A57D8-A038-4103-99B8-8617E109AADFQ35089099-ECE5681A-20CB-47E7-B412-2E20FCEC96EAQ35648983-03F37864-53C5-4A58-B3AB-408ECE2FED57Q35821515-44DF8E54-DCD9-4E53-B724-2F44158CFF52Q35986076-3DB635B0-BADF-4120-8A92-AA2A7410560DQ36153216-79D14939-5725-4345-B7DE-1B36A42A044CQ36211439-D1AA8A53-132B-4C59-8AEB-D5366B8D9F8CQ36806399-5201F95E-7FCC-4E62-BA44-667FFB04D435Q36844338-F3DD8922-802D-4823-918D-2B9DF1F514FEQ37056101-D8C0A005-1A08-4089-97B2-4ED165B0AFBCQ37104031-DF0133F2-EC6F-43C6-B223-868E5D005892Q37348942-DA5986CE-1BA5-46B9-AC8C-745981B36FB0Q37355041-6095477E-8E21-46A6-A51A-1D7D42964A88Q37377856-8D88D773-4D78-4F23-8E14-E2AC1B56C038Q38261684-CDBEBAC2-BE18-401C-9CED-3EA7C556E187Q38612785-F27B5FD4-DAEF-4EDE-B123-6097D70098FEQ39250380-8378F29F-C394-4C73-AC24-98862235CE8EQ39860663-D677DA62-0686-42E5-8972-9D1E9050A169Q40071985-1BE8F248-BE97-49C4-8E02-030859D6E8DCQ41250251-F6BEBE8A-EC08-422D-B5BD-538009FECA3CQ42153181-8F63CD64-AAD7-48DB-A9CA-CE53AE0CBD42Q42160566-335A2EF0-6020-490B-8554-128581E4236FQ42258998-C79C2A0C-0277-4C53-9EF6-8159F02299FCQ42515049-73553D23-DD69-4EAE-8294-D253E8F77673Q44414596-2FDEC0E4-8D0A-4A3B-99D2-ECC2F4403B58Q46016127-6C91835A-AA89-44B4-A5EE-F914C11B99D2Q48367482-3CBE9664-79FD-4ADB-ADFA-D41136326E98Q48566027-A69E8339-B59A-4A5A-A3B9-DF3492DC8658Q48637828-D7384EDB-2DFE-4174-8C1C-DE46B2291B38Q54364555-C66C2D79-4360-490A-9595-B013B5F9AACB
P2860
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
1989年论文
@zh
1989年论文
@zh-cn
name
VIP: molecular biology and neurobiological function.
@en
type
label
VIP: molecular biology and neurobiological function.
@en
prefLabel
VIP: molecular biology and neurobiological function.
@en
P356
P1476
VIP: molecular biology and neurobiological function.
@en
P2093
D E Brenneman
P2888
P304
P356
10.1007/BF02740606
P577
1989-01-01T00:00:00Z
P6179
1038689304